Spinnaker Investment Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$549K Buy
22,810
+12,211
+115% +$319K 0.09% 92
2026
Q1
$298K Sell
10,599
-883
-8% -$23.5K 0.06% 108
2025
Q4
$286K Sell
11,482
-31
-0.3% -$782 0.05% 135
2025
Q3
$293K Buy
+11,513
New +$284K 0.06% 126
2024
Q4
Sell
-8,249
Closed -$239K 98
2024
Q3
$239K Buy
8,249
+541
+7% +$15.8K 0.06% 85
2024
Q2
$216K Buy
+7,708
New +$212K 0.06% 75
2023
Q4
Sell
-6,105
Closed -$203K 90
2023
Q3
$203K Buy
+6,105
New +$216K 0.07% 82
2023
Q2
Sell
-5,045
Closed -$206K 86
2023
Q1
$206K Buy
5,045
+32
+0.6% +$1.38K 0.07% 82
2022
Q4
$257K Buy
5,013
+285
+6% +$13.7K 0.09% 76
2022
Q3
$207K Buy
+4,728
New +$230K 0.08% 79
2022
Q2
Sell
-4,278
Closed -$226K 85
2022
Q1
$226K Buy
4,278
+255
+6% +$13.2K 0.07% 79
2021
Q4
$215K Buy
+4,023
New +$199K 0.08% 87

Other funds holding PFE

Spinnaker Investment Group's PFE Position: Q2 2026 in Review

Spinnaker Investment Group increased its Pfizer (PFE) stake by 115% in Q2 2026, buying an estimated $319K and bringing the position to 22,810 shares worth $549K. The position accounts for 0.09% of the portfolio, ranked #92.

Spinnaker Investment Group first reported a position in PFE in Q4 2021 and has held it in 12 quarters since. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Spinnaker Investment Group held 22,810 shares of Pfizer worth $549K as of Q2 2026.
  • Spinnaker Investment Group bought 12,211 Pfizer shares in Q2 2026, an estimated $319K.
  • Pfizer made up 0.09% of Spinnaker Investment Group's portfolio in Q2 2026, its #92 holding.
  • Spinnaker Investment Group first reported a position in Pfizer in Q4 2021 and has held it in 12 quarters since.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Spinnaker Investment Group's 13F filing for Q2 2026, filed 10 Jul 2026.